Johnson & Johnson just got some new ammo for its defense against lawsuits claiming its talc products caused ovarian cancer. A new data analysis—the largest ever on the subject—found no statistically significant increase in cancer risk for powder users. The
read moreComplex Innovative Design trials are increasingly being used as an evaluation method by researchers instead of traditional drug development pathways More: New recommendations could get innovative treatments to cancer patients quicker Source: News
read moreJust 0.4% of GPs and 0.1% of nursing, midwifery and other health professionals had research as part of their role in 2017. More: ‘Urgent changes’ needed to avert health research ‘crisis’ Source: News
read moreBack in October 2019 a WHO World Vision Report found that more than one billion people worldwide are living with sight loss, which is contributed to by a lack of investment in eye care and research. More: Eyesight leaders urge
read moreThe partnership is set to combine MiNA’s “leading expertise” with AstraZeneca’s experience in identifying and bringing breakthrough treatments to patients with metabolic diseases. More: AZ brings MiNA on board to fight metabolic diseases Source: News
read moreGalen first signed a distribution agreement with POA back in April 2016. More: Galen takes over POA Pharma, expands reach Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals